These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25137252)

  • 21. Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation.
    Bornstein R; García-Vela J; Gilsanz F; Auray C; Calés C
    Br J Haematol; 2001 Aug; 114(2):458-65. PubMed ID: 11529870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombopoietin enhances hematopoietic stem and progenitor cell homing by impeding matrix metalloproteinase 9 expression.
    Liu Y; Ding L; Zhang B; Deng Z; Han Y; Wang S; Yang S; Fan Z; Zhang J; Yan H; Han D; He L; Yue W; Wang H; Li Y; Pei X
    Stem Cells Transl Med; 2020 Jun; 9(6):661-673. PubMed ID: 32125099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cotransplantation of ex vivo expanded progenitors with nonexpanded cord blood cells improves platelet recovery.
    Émond H; Boyer L; Roy DC; Pineault N
    Stem Cells Dev; 2012 Nov; 21(17):3209-19. PubMed ID: 22783996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo expansion of enriched CD34+ cells from neonatal blood in the presence of thrombopoietin, a comparison with cord blood and bone marrow.
    Liu J; Li K; Yuen PM; Fok TF; Yau FW; Yang M; Li CK
    Bone Marrow Transplant; 1999 Aug; 24(3):247-52. PubMed ID: 10455361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo expansion of cord blood-CD34(+) cells using IGFBP2 and Angptl-5 impairs short-term lymphoid repopulation in vivo.
    Ventura Ferreira MS; Labude N; Walenda G; Adamzyk C; Wagner W; Piroth D; Müller AM; Knüchel R; Hieronymus T; Zenke M; Jahnen-Dechent W; Neuss S
    J Tissue Eng Regen Med; 2013 Dec; 7(12):944-54. PubMed ID: 22653714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential.
    McNiece IK; Almeida-Porada G; Shpall EJ; Zanjani E
    Exp Hematol; 2002 Jun; 30(6):612-6. PubMed ID: 12063029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombopoietin is a major limiting factor for selective outgrowth of human umbilical cord blood cells in non-obese diabetic/severe combined immunodeficient recipient mice.
    Verstegen MM; Wognum AW; Wagemaker G
    Br J Haematol; 2003 Sep; 122(5):837-46. PubMed ID: 12930398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
    Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
    Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells.
    Bruno S; Gunetti M; Gammaitoni L; Perissinotto E; Caione L; Sanavio F; Fagioli F; Aglietta M; Piacibello W
    Stem Cells; 2004; 22(2):135-43. PubMed ID: 14990853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo evidence that ex vivo cytokine priming of donor marrow cells may ameliorate posttransplant thrombocytopenia.
    Ratajczak MZ; Ratajczak J; Machalinski B; Mick R; Gewirtz AM
    Blood; 1998 Jan; 91(1):353-9. PubMed ID: 9414305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
    Proulx C; Boyer L; Hurnanen DR; Lemieux R
    J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma.
    Qiu X; Jiang H; Xiao X; Huang L; Xu Y
    Transfus Apher Sci; 2024 Oct; 63(5):103972. PubMed ID: 39013350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.
    Piacibello W; Bruno S; Sanavio F; Droetto S; Gunetti M; Ailles L; Santoni de Sio F; Viale A; Gammaitoni L; Lombardo A; Naldini L; Aglietta M
    Blood; 2002 Dec; 100(13):4391-400. PubMed ID: 12453876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single thrombopoietin dose alleviates hematopoietic stem cells intrinsic short- and long-term ionizing radiation damage. In vivo identification of anatomical cell expansion sites.
    Tronik-Le Roux D; Nicola MA; Vaigot P; Nurden P
    Radiat Res; 2015 Jan; 183(1):52-63. PubMed ID: 25564715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models.
    Zibara K; Hamdan R; Dib L; Sindet-Pedersen S; Kharfan-Dabaja M; Bazarbachi A; El-Sabban M
    PLoS One; 2012; 7(7):e40140. PubMed ID: 22768336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.
    Moscardó F; Sanz J; Senent L; Cantero S; de la Rubia J; Montesinos P; Planelles D; Lorenzo I; Cervera J; Palau J; Sanz MA; Sanz GF
    Haematologica; 2009 Jun; 94(6):827-32. PubMed ID: 19483157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose.
    Keever-Taylor CA; Klein JP; Eastwood D; Bredeson C; Margolis DA; Burns WH; Vesole DH
    Bone Marrow Transplant; 2001 Apr; 27(8):791-800. PubMed ID: 11477435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.